Results 161 to 170 of about 54,939 (306)

COVID19‐Related Onset and Relapses of Juvenile Systemic Lupus Erythematosus‐Like Disease

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Chiara Cannata   +3 more
wiley   +1 more source

FIGO guideline on liver disease and pregnancy

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 170, Issue 1, Page 28-48, July 2025.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana   +24 more
wiley   +1 more source

Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model

open access: bronze, 2012
Cong Jin   +23 more
openalex   +1 more source

A Case of Hemophagocytic Lymphohistiocytosis During Immune Checkpoint Inhibitor Treatment for Metastatic Renal Cell Carcinoma, Complicated by Pancytopenia Attributed to Cytomegalovirus Infection

open access: yesIJU Case Reports, Volume 8, Issue 4, Page 423-426, July 2025.
ABSTRACT Introduction Hemophagocytic lymphohistiocytosis (HLH) is characterized by macrophage and cytotoxic lymphocyte hyperactivation, fever, pancytopenia, liver dysfunction, and abnormal coagulation. However, no specific treatments have been established for HLH caused by immune checkpoint inhibitors.
Tomoko Honda   +9 more
wiley   +1 more source

Cytokine and Chemokine Levels in Patients with Severe Fever with Thrombocytopenia Syndrome Virus

open access: gold, 2012
Baocheng Deng   +17 more
openalex   +2 more sources

Indication‐Specific Dosing and Dose‐Evaluation Strategies in New Indications for Non‐Oncology Monoclonal Antibodies

open access: yesThe Journal of Clinical Pharmacology, Volume 65, Issue 7, Page 895-908, July 2025.
Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley   +1 more source

Proven invasive pulmonary aspergillosis in the early clinical course of severe fever with thrombocytopenia syndrome: Importance of an early diagnosis

open access: yesJournal of Microbiology, Immunology and Infection, 2021
Gil Myeong Seong   +6 more
doaj  

An Epidemic of Respiratory and Ocular Infections Caused by the Reemergence of a Recombinant Human Adenovirus, the Novel Type HAdV‐B114 (P7H3F3)

open access: yesJournal of Medical Virology, Volume 97, Issue 7, July 2025.
ABSTRACT Human adenoviruses of species B (HAdV‐B) can cause upper respiratory tract infections and conjunctivitis, but also severe lower respiratory tract infections (LRTI). Although HAdV‐associated LRTI are non‐notifiable in Germany, typing data of our Adenovirus Reference Laboratory indicated an HAdV‐B3 epidemic in 2023, with 67 samples initially ...
Tina Ganzenmueller   +5 more
wiley   +1 more source

Two confirmed cases of severe fever with thrombocytopenia syndrome with pneumonia: implication for a family cluster in East China [PDF]

open access: gold, 2017
Yiyi Zhu   +8 more
openalex   +1 more source

Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors

open access: yesMedComm, Volume 6, Issue 7, July 2025.
CVL218, a PARP1/2 inhibitor, was generally well tolerated and safe in solid tumors. It showed potential antitumor activity in patients treated with the recommended dose (700 mg BID). ABSTRACT CVL218, a novel poly ADP‐ribose polymerase (PARP1/2) inhibitor, has strong PARP1/2 selective inhibitory activity and high oral bioavailability. We aimed to assess
Zihong Chen   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy